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Abstract
Quantitative phase imaging and digital holographic microscopy have shown great
promise for visualizing the motion, structure and physiology of microorganisms and
mammalian cells in three dimensions. However, these imaging techniques currently
lack molecular contrast agents analogous to the ﬂuorescent dyes and proteins that
have revolutionized ﬂuorescence microscopy. Here we introduce the ﬁrst genetically
encodable phase contrast agents based on gas vesicles. The relatively low index of refraction of the air-ﬁlled core of gas vesicles results in optical phase advancement relative
to aqueous media, making them a “positive” phase contrast agent easily distinguished
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from organelles, dyes, or microminerals. We demonstrate this capability by identifying and tracking the motion of gas vesicles and gas vesicle-expressing bacteria using
digital holographic microscopy, and by imaging the uptake of engineered gas vesicles
by mammalian cells. These results give phase imaging a biomolecular contrast agent,
expanding the capabilities of this powerful technology for three-dimensional biological
imaging.

Keywords
Quantitative Phase Imaging (QPI), Oﬀ-Axis Digital Holographic Microscopy, Volumetric
Imaging, Phase Contrast Agent, Gas Vesicles, Reporter Genes, 3D Particle Tracking

Introduction
Precise acquisition of 4-dimensional data, comprising spatial coordinates and time, is important for studying many microscopic processes in biology. However, conventional optical
microscopy suﬀers from a narrow depth of ﬁeld due to its reliance on focusing lenses to encode spatial depth. Volumetric information is only obtained through step-wise acquisition of
points or planes, and the resulting sequential acquisition typically necessitates low resolution
in at least one of the 4 dimensions. Oﬀ-axis digital holographic microscopy (OADHM), an inherently volumetric recording technique, provides an alternative for instantaneous sampling
of thick volumes. Successful applications have been made to studies of microbial motility,
chemotaxis, ﬂow of ions through ion channels, and migration of cancer cells 1–7 including the
use of 3-dimensional phase tomograms. 8,9
With OADHM, optical interferometry is used to record a series of holograms at frame
rates limited only by the camera. Oﬀ-line reconstruction yields plane-by-plane images of
image intensity (brightﬁeld) and phase. In OADHM, as in other forms of quantitative phase
imaging (QPI), phase contrast at any point x, y is related to the diﬀerence in indices of
2

refraction between the medium (nm ) and objects in the light path (nc ) multiplied by the
object height h: 10
Δφ =

2π
h(x, y)(nm − nc (x, y)),
λ

(1)

Because the typical values of nc for the cytoplasm and organelles are approximately
1.38, 11–13 which is very close to the nm of 1.33 for water, it is challenging for OADHM
to visualize prokaryotic cells with much speciﬁcity, particularly when they are near the
resolution limit of the instrument. 14 This challenge could be overcome with suitable contrast
agents or reporter genes, which would make cells more visible or highlight subcellular features
and processes.
In ﬂuorescence microscopy, this function is provided by targeted small-molecule dyes
and ﬂuorescent proteins, which have revolutionized the utility of this technique in biological research. 15–18 Unfortunately, these same molecules are not eﬀective as phase contrast
agents. 19–23 Although dyes create phase contrast related to absorbance by the KramersKronig relations, 23 the necessary concentrations to create useful contrast cause cytotoxicity
or, in the case of genetically encoded proteins, are impossible to achieve. Some designs for
coupling OADHM with ﬂuorescence imaging have been implemented, but they are complicated due to the incoherent nature of ﬂuorescence emission and its weak signal. 24–26
These issues can be addressed with genetically encodable phase contrast agents. An
ideal phase contrast agent would have a more dramatically diﬀerent index of refraction, and
preferably one that is lower than that of H2 O to be categorically distinguishable from other
cellular components. Furthermore, an ideal contrast agent would demonstrate low toxicity
to cells and be capable of sub-cellular targeting.
Here we introduce genetically encodable contrast agents for phase imaging. These contrast agents are based on a unique class of hollow protein nanostructures called gas vesicles
(GVs). GVs are all-protein nanostructures natively expressed in a number of waterborne
microorganisms as a means to regulate their buoyancy. 27,28 GVs are air-ﬁlled compartments
with dimensions on the order of 200 nm, enclosed by a 2 nm-thick protein shell (Figure
3

1A), which is permeable to dissolved gas but prevents water from condensing into a liquid
in the GV core. GVs have previously been described as contrast agents for ultrasound 29
and magnetic resonance imaging, 30–32 but have not been applied to optical microscopy. Recently, the genes encoding GVs have been heterologously expressed in commensal bacteria
(e.g. Escherichia coli Nissle 1917 and Salmonella typhimurium) 31,33 and mammalian cells. 34
In this work, we test the hypothesis that the large diﬀerence in the index of refraction
of GVs’ gaseous interior (n = 1.0) relative to water and cytoplasm would produce strong
positive phase contrast. We use a OADHM system capable of providing sub-micron resolution to visualize the phase contrast produced by puriﬁed GVs, allowing 4-dimensional
tracking of their motion. In addition, we show that S. typhimurium cells expressing GVs
as a genetically encoded reporter produce a unique pattern of phase contrast reﬂecting the
sub-cellular distribution of these nanostructures. Furthermore, we demonstrate the use of
GVs as targeted molecular contrast sources in mammalian cells by visualizing the uptake of
engineered GVs into a mammalian cell line. This work establishes GVs as a tool for molecular and genetically encodable phase contrast, greatly expanding the utility of OADHM and
related methods.

Results and discussion
Gas vesicles produce positive phase contrast
To establish the ability of GVs to produce phase contrast, we imaged GVs puriﬁed from Anabaena ﬂos-aquae. These nanostructures are approximately 120-140 nm wide and 200-800
nm long as measured by transmission electron microscopy (TEM) (Figure 1A). Individually, puriﬁed GVs were too small to resolve on our OADHM system, which uses numerical
aperture (NA) of 0.3 aspheric lenses to achieve a spatial resolution of 0.8 µm (Figure 1B).
We therefore assembled GV clusters by biotinylation of the GVs followed by the addition of
streptavidin. This yielded clusters with hydrodynamic diameters of 690±56 nm (Figure 1C
4
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Figure 1: Gas vesicles as phase contrast agents. (A) Schematic of a single GV, indicating the
index of refraction, n, inside the GV and in typical aqueous media. (B) Schematic of common
path OADHM system used in this work, and an illustration of the inherent volumetric
imaging of OADHM compared to conventional microscopy. (C) Biotinylated GVs puriﬁed
from Anabaena ﬂos-aquae can be clustered using streptavidin. Shown are a schematic and
representative transmission electron micrograph of biotinylated GVs (top) and clustered
GVs (bottom). Scale bars 100 nm and 500 nm, respectively. (D) Representative OADHM
phase and intensity images of clustered GVs and alumina beads. Scale bars represent 10
µm. (E) Histogram of phase change observed from clustered GVs with apparent diameters
from 0.6-2.2 µm.
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and Supplemental Figure 1). Holograms were collected of GV clusters and of comparably
sized alumina beads (1524±470 nm diameter as measured by dynamic light scattering) suspended in phosphate-buﬀered saline (PBS). We reconstructed these holograms into phase
and intensity images as described in the supplementary text and Supplemental Figure 2. The
phase shifts from the GV clusters and alumina beads were opposite in sign, with the GV
clusters exhibiting positive phase contrast, while the alumina beads exhibited negative phase
contrast (Figure 1D). Both particles appear dark in intensity images due to light scattering.
The average phase shift produced by the GV clusters was 0.4±0.32π (Figure 1E). GV phase
contrast could be erased by irreversibly collapsing the GVs with hydrostatic pressure, 35 providing a convenient internal control. After collapse, the positive phase contrast of GVs was
eliminated (Supplemental Figure 3).
Having established GVs as phase contrast agents, we sought to determine if OADHM
could be used to distinguish them and track their motion in a mixed particle population. 36
First, we tracked the motion of both GV clusters and alumina beads in a 1 mm-deep well.
The average speed of GV clusters rising along the depth axis due to their buoyancy was
0.43±0.58 µm s−1 (95% C.I.) (Figure 2A-C), while alumina beads sank with an average
speed of –0.47±1.02 µm s−1 (95% C.I.) (Figure 2D-F). When GV clusters and alumina
beads were mixed together and tracked, the two particle types were readily distinguished
(Figure 2G-J), with the particles that were rising having positive phase contrast and the
particles that were sinking having negative phase contrast (Figure 2K) with both particles
appearing negative in intensity images (Supplemntary Figure 4). This demonstrated the
ability of GVs to serve as a categorical contrast agent for 4-dimensional OADHM.

Engineered gas vesicles serve as targeted contrast agents
Among the advantages of GVs as phase contrast agents is their ability to be genetically
engineered to modify their surface biochemical properties and enable molecular targeting. 35,37
To demonstrate that engineered, targeted GVs could be used for phase imaging in living cells,
6
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Figure 2: Volumetric tracking of particles in a mixed population suspension. (A) 3D trajectory plots of tracked GVs over 60 seconds. (B) Clustered GVs rise in solution (Top).
Histogram of the z-component velocities of clustered GVs (Bottom). (C) Two example 3D
tracks of clustered GVs. Each trajectory is color-coded with respect to time. (D) 3D trajectory plots of tracked alumina beads over 60 seconds. (E) Alumina beads sink over time
(Top). Histogram of z-component velocities of alumina particles (Bottom). (F) Two example 3D tracks of alumina beads. Each trajectory is color-coded with respect to time.
(G) 3D trajectory plots of the mixed population over 60 seconds. (H) Mixed population of
clustered GVs and alumina beads. (I) Velocity histograms show two velocity populations,
one for GVs and another for alumina beads. (J) Example trajectory of a rising and another
of sinking particle chosen at random from G. (K) Phase images of the two particles from J.
The buoyant particle has a positive phase contrast while the particle sinking has a negative
phase contrast. Scale bars represent 5 µm.
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we used a fusion of the A. ﬂos-aquae sequence to a polyarginine (R8) peptide. This peptide
is a mimic of the human immunodeﬁciency virus 1 trans-activating (HIV-1 TAT) peptide
and allows tagged proteins and particles to penetrate into mammalian cells (Figure 3A). 38
Polyarginine-modiﬁed GVs were puriﬁed and added to Chinese hamster ovary (CHO) cells
at 114 pM for 45 minutes, washed and imaged by a OADHM system. This allowed for
rapid 3-dimensional reconstruction of GV location on the surface of and within the cells
(Figure 3B-D). GVs were ﬂuorescently labeled with Alexa Fluor 488-NHS ester dyes to
independently conﬁrm the location of GV labeling on the cells (Figure 3E & 3F). These
experiments demonstrate the ability of GVs to label living cells for 3-dimensional phase
imaging.

Gas vesicles as genetically expressed contrast agents in Salmonella
typhimurium
Following the characterization of GVs as targeted OADHM contrast agents, we tested the
ability of genetically encoded GVs to act as phase contrast reporter genes in living bacteria. A recently developed gene cluster encoding GVs, comprising a combination of genes
from Anabaena ﬂos-aquae and Bacillus megaterium, 33 was used to heterologously express
GVs in Salmonella typhimurium – a commonly used commensal bacteria for a number of
cellular therapeutics applicaitons 39 (Figure 4A). Upon induction with N-(β-ketocaproyl)L-homoserine lactone (AHL), Salmonella formed numerous intracellular GVs, which were
visualized under TEM and seen to typically cluster into distinct subcellular regions (Figure
4B). This pattern was expected to perturb the electromagnetic wavefront passing through
a GV-expressing Salmonella cell so as to produce a distinct pattern in phase and intesnity
images, as shown in simulated holograms (Figure 4C & 4D, Supplemental Text).
As expected, under OADHM, GV-expressing Salmonella exhibited clear phase contrast
that was diﬀerent from control cells in which the GVs had been collapsed with hydrostatic
pressure. 35 Phase values of interior cellular regions of 50 GV-expressing salmonella cells
8
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Figure 3: OADHM imaging of mammalian cells labeled with engineered gas vesicles. (A)
Diagram of engineered GVs genetically functionalized with R8 peptides for attachment to and
internalization by mammalian cells. Illustration of mammalian cells labeled with R8-GVs.
(B) OADHM phase image of CHO cells labeled with R8-GVs. (c) Intesntiy image of CHO
cells labeled with R8-GVs. Scale bar represents 25 µm. (D) Pseudocolored 3D rendering of
GVs decorating CHO cells. For details see supplemental text. (E) Phase image of CHO cells
labeled with Alexa Fluor 488 conjugated R8-GVs under the high power OADHM showing
positive phase contrast in correspondence with (F) a ﬂuorescence image of the same CHO
cells. Arrows indicate corresponding regions in E and F. All scale bars represent 25 µm.
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were analyzed and found to exhibit an average phase value of 0.06±0.05π (95% C.I., n = 50
cells) (Figure 4E & 4G). The subcellular regions of these cells which contained high GV
concentrations exhibited even higher phase values of 0.42±0.10π (95% C.I., n = 110 subcellular regions). The phase values of interior cellular regions of 50 GV-expressing Salmonella
cells after their GVs were hydrostatically collapsed were measured to be -0.06±0.10π (95%
C.I., n = 50 cells) (Figure 4F & 4G). The histogram of all pixels in Salmonella cells with
and without GVs illustrates increased phase contrast due to GV-expression (Figure 4H).
GV-expression increased the average signal to noise ratio of Salmonella cells in phase images
by more than three-fold, making the cells easier to detect in solution.
Our results demonstrate that GVs serve as molecular and genetically encodable contrast
agents for phase imaging due to the large diﬀerence in their index of refraction compared
with aqueous media and organelles, resulting in positive phase contrast. The opposite sign
of their refractive index diﬀerence from water compared to most other biological structures
is especially beneﬁcial for studying small samples such as microorganisms or subcellular features. The rapid volumetric image acquisition of OADHM makes it possible to identify and
dynamically track GVs in a mixed solution containing other particles showing not only its
ability to image a large volume at high resolution but its ability to maintain phase sensitivity
across its depth of ﬁeld. In addition, the modular protein make-up of GVs enables protein engineering to confer novel targeting properties for cellular imaging. This may facilitate future
studies of cell-nanoparticle interactions and other dynamic cellular processes. Furthermore,
by introducing GV gene encoded phase contrast, allowing cells activated to express these reporter genes to be distinguished from cells without reporter expression. These studies result
in a QPI toolkit that will permit speciﬁc labeling in a large number of biological scenarios.
While the results presented in this study provide the key scientiﬁc evidence supporting
the ability of GVs to serve as genetically encoded reporters for phase imaging, future work
is needed to apply these agents to speciﬁc biological problems. To enable such applications,
there exists signiﬁcant scope for improvement and optimization. In using GVs as a contrast
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Figure 4: Gas vesicles as genetically encoded phase contrast agents in Salmonella. (A)
Schematic of engineered GV gene cluster comprising genes from Anabaena ﬂos-aquae (orange genes) and Bacillus megaterium (blue genes) that enable heterologous expression of
GVs in Salmonella typhimurium. (B) Representative transmission electron micrograph of
S. typhimurium expressing GVs. Inset is a 2x zoom in of a GV containing region of the
salmonella cell. Scale bar represents 1 µm. (C) Numerical simulation of phase images of
a GV-expressing Salmonella cell. (D) Numerical simulation of intensity images of a GVexpressing Salmonella cell. Scale bar represents 1 µm. (E) Representative phase (left) and
intensity (right) images of GV-expressing S. typhimurium cells under OADHM. (F) Representative phase (left) and intensity (right) images of GV-expressing S. typhimurium cells
after collapsing GVs using 1.2 MPa of hydrostatic pressure. Zoomed in images of a representative cell from E and F are shown on the bottom. Scale bars for full ﬁeld of view are
25 µm, and 5 µm for the zoomed in images. (G) Quantiﬁed average phase contrast from
S. typhimurium cells with intact GVs compared with collapsed GVs (n = 50 cells). (H)
Histogram of quantiﬁed phase contrast from all pixels in S. typhimurium cells with intact
GVs (n = 50 cells) compared with collapsed GVs (n = 50 cells).
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agent for arbitrary samples, phase wrapping must be considered. In a typical QPI system,
phase measurements are constrained to a modulo-2π (e.g. -π to π). As a result, samples
that introduce a phase shift of φ = 2π + m, will only be seen to show a phase shift of m.
Targeted eﬀorts in the development of robust phase unwrapping algorithms will aid in the
use of GVs in arbitrarily thick samples, eliminating the loss of contrast due to wrapping,. 40–45
Furthermore, robust phase unwrapping algorithms are needed to prevent the loss of positive phase contrast of GVs due to the thick negative phase contrast of typical intracellular
material. Given the ability of GVs to be collapsed with acoustic pressure, additional contrast speciﬁcity could be obtained by integrating the ability to apply ultrasound waves to
OADHM samples in situ and monitoring the resulting change in phase. 31,33,35 In addition,
the engineering of GV variants that collapse under diﬀerent applied pressures may enable
multiplexed phase contrast imaging. But it is expected that the greatest use of the technique will be in small, low-contrast cells and features, particularly for long-term recordings
where phototoxicity of dyes and ﬂuorescent proteins is a concern. Other immediate areas of
application could be long-term, 4-dimensional tracking of bacterial motility and chemotaxis;
engineering of subcellular- (e.g. mitochondrial) targeted GVs in order to explore changes in
organelle shape and size with altered conditions; multimodal labeling to couple QPI with
ultrasound and/or magnetic resonance imaging, particularly incorporating holographic tomography, for detection of labeled cancer cells or subcellular features. Furthermore, while
genetic encoding facilitates the use of GVs to study genetically tractable organisms, there
is also substantial interest in using OADHM for ﬁeld studies, taking advantage of the microscopes’ robust solid-state design. 46 In such studies, the relevant microorganisms may be
genetically intractable or their genetics entirely unknown, requiring the development of targeting moieties to bind GVs to such species. Such labeling would additionally facilitate the
application of tracking and machine learning algorithms to the detection of small, near resolution limit, microorganisms in 4-dimensional data, where low image contrast is currently a
challenge. 47 As with all labeling techniques, possible cytotoxicity will need to be evaluated
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in the test system of interest. For studies of microbial behaviors such as motility and chemotaxis, it will be necessary to quantify the eﬀect of genetically encoded and/or aptamer-bound
GVs on these behaviors. We have seen elongation of Salmonella cells overexpressing GVs,
indicating inhibition of cell division, and possible reduced motility. Extracellular labeling or
reducing the expression levels may solve this problem. We anticipate that the development
of dedicated molecular and genetically encodable contrast agents will usher in a new phase
in holographic microscopy.
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(ﬁle type, TIFF)
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